Irvine-based Edwards Lifesciences Corp. said Wednesday it plans to sell its perfusion products business to the Nipro Group, a Japanese medical device maker.
Edwards didn’t disclose financial terms, but said it expects to close the deal in the fourth quarter.
The unit has produced about $2 million in profit and $20 million in sales for Edwards this year.
Nipro’s Brazilian unit, Nipro Medical Ltda., will take on the Edwards perfusion unit, which is based is Sao Paulo. About 140 of Edwards’ workers in the unit will go to Nipro Medical.
Perfusion uses artificial blood pumps to propel blood through the bodies of surgical patients, replacing the function of the heart when cardiac surgeons operate.
Edwards, which is primarily a replacement heart valve maker, has sold off its various perfusion products operations in the U.S., Japan and Western Europe since 2000.
